Research Centers of Excellence
Dr. Gabriel G. Malouf MD, PhD provides a good overview of rare kidney cancers at the molecular level for patients and physicians.
Presented at the 2016 GUASCO conference in San Francisco
Due to their small population, few resources and fewer clinical trials are devoted exclusively to patients with rare kidney cancer (also call "non clear cell renal cell carcinoma" or nccRcc).
TRI-CON, the molecular Medicine conference, is holding a hackathon on March 3rd and 4th, 2020 at Moscone Center in San Francisco in conjunction with Ben Busby, research to the people and rarekidneycancer.org. The hackathon free to attend,
Bill Paseman, CTO of rarekidneycancer.org, recently spoke at the National Cancer Institute (NCI) symposium “Cancer Moonshot Symposium on patient/participant-controlled data sharing”, held on September 26-27, 2019 in Bethesda, MD.
No partners have been featured.
Copyright © 2016